Introduction {#sec1}
============

*Xenorhabdus nematophila*, a type of motile Gram-negative bacteria, lives in symbiosis with the entomopathogenic nematode *Steinernema carpocapsae.*([@ref1]−[@ref3]) These bacteria colonize in a specialized intestinal receptacle of the infective juvenile (IJ) form of the nematode, and together, they form an entomopathogenic complex that can infect and kill different insects.^[@ref2],[@ref4]−[@ref6]^ To survive, the nematodes search for a susceptible insect host in soil, perforating the insect's intestinal wall and migrating into the hemocoel. Once in the hemocoel, the nematode releases *X. nematophila* into the insect host's hemolymph, and the bacteria produce immunosuppressive compounds and insect toxins to overcome the host immune system and kill it.^[@ref7]−[@ref11]^ As colonies of *X. nematophila* proliferate to a high cell density, they secrete exoenzymes that degrade insect tissues and antibiotics for suppressing the growth of microbial competitors.^[@ref12]−[@ref20]^*S. carpocapsae* then propagates in the hemocoel feeding on *X. nematophila* as well as the nutrients derived from the insect source. With the depletion of nutrients, the nematodes develop into the IJ stage; thereafter, they emerge from the insect cadaver into the soil in search for a new insect host.^[@ref3],[@ref4],[@ref21]^

In the life cycle of the entomopathogenic *S. carpocapsae*--*X. nematophila* complex, *X. nematophila* produces several compounds with antimicrobial activity, including indole derivatives, nematophin, benzylideneacetone, xenocoumacins, and nonribosomal produced secondary metabolites.^[@ref1],[@ref17],[@ref19],[@ref22]−[@ref29]^ Among them, the water-soluble peptide antimicrobial compounds, Xcns, such as xenocoumacin 1 (Xcn1, C~22~H~35~N~5~O~6~) and xenocoumacin 2 (Xcn 2, C~21~H~30~N~2~O~6~) shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, are the major antibiotics produced in the broth culture by *X. nematophila.*([@ref30],[@ref31]) Biosynthesis of Xcns is associated with a 39 kb cluster of 14 genes that include two nonribosomal peptide synthetases (NRPS) and three polyketide synthases (PKSs) ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)).^[@ref32]^ Although both Xcns show antimicrobial activity, Xcn1 is much more active in its antifungal activity. However, the accumulation of Xcn1 is toxic to the producing cells. To avoid self-toxicity *X. nematophila* had evolved a resistance mechanism by converting Xcn1 to the weaker antibiotic Xcn2. The responsible genes are *xcnM* and *xcnN*, which encode proteins homologous to saccharopine dehydrogenases and fatty acid desaturases, respectively.^[@ref32]−[@ref34]^ On the other hand, Xcn1 and Xcn2 can be hydrolyzed to Xcn5 and Xcn6, respectively ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), which is another detoxification pathway.^[@ref35]^

![Proposed conversion pathways among Xcn1, Xcn2, Xcn5, and Xcn6 as reported previously.^[@ref35]^](ao0c02357_0001){#fig1}

Prompted by the broad-spectrum antibiotic activity of Xcn1, Yang et al. explored its potential as a novel fungicide for biocontrol of *Phytophthora infestans*([@ref36]) that causes potato late blight disease. Potato late blight disease is one of the most devastating plant diseases worldwide, which destroyed potato crops in Europe in the 1840s and caused mass starvation.^[@ref37]^ Currently, *P. infestans* is still one of the major pathogens targeted by chemical companies searching for new fungicides. Yang et al. showed that Xcn1 not only inhibited mycelial growth of *P. infestans*, reaching 100% inhibition at 1.5 μg/mL Xcn1, but also suppressed sporangia production. Additionally, Xcn1 also exhibits strong antifungal activity against other species of *Phytophthora*, with EC~50~ values ranging from 0.25 to 4.17 μg/mL.^[@ref36],[@ref38]^ To sum up, Xcn1 possesses great potential to be developed into a novel biofungicide utilized for plant protection. However, the detoxification mechanism leading to the degradation of Xcn1 prevents its accumulation in the fermentation process, therefore limiting its commercial applications.

In situ product removal (ISPR) involves the immediate separation of a product from its producing cells; therefore, it could improve the yield of the product via two possible effects: minimization of interference resulting from product accumulation from the producing cells and minimization of product losses caused by the cross interaction with the enzymes produced by the producing cells and environmental conditions.^[@ref39],[@ref40]^ In addition, this technique could also simplify the downstream processing steps.^[@ref41]^ To date, most studies involving ISPR focused on acetone, butanol, and ethanol as well as organic acid fermentation with organic solvents, ion-exchange resins, and adsorbent polymers as the widely used separation materials.^[@ref42],[@ref43]^

In this study, ISPR based on macroporous resins was explored in the fermentation process of *X. nematophila* CB6 to improve the yield of Xcn1. In addition, the underlying reasons for an improved yield were also explored.

Results and Discussion {#sec2}
======================

Improving the Yield of Xcn1 by In Situ Product Removal {#sec2.1}
------------------------------------------------------

Helped by Xcn1, which exhibits a broad-spectrum antibiotic activity against bacteria and several fungal species, *X. nematophila* could efficiently protect the nutrient resources of the insect cadaver against food competitors from soil microorganisms, while excess Xcn1 is also toxic against the producer itself. As a result, accumulated Xcn1 during fermentation could activate a defense mechanism of *X. nematophila* to avoid self-toxicity by converting Xcn1 to weak antibiotic Xcn2 and other related derivatives, which would limit the commercial process of Xcn1 production.^[@ref35]^ In addition, to the best of our knowledge, there is no chemical route reported for the synthesis of Xcn1 or its derivatives. Therefore, in an attempt to improve the yield of Xcn1, ISPR, an efficient method for rescuing the fermentation process limited by inhibitory or toxic products as well as unstable products, was employed to limit the conversion from Xcn1 to Xcn2 as well as other derivatives. In routine cultivation, the yield of Xcn1 as well as Xcn2 reached a plateau in two days, then decayed rapidly, and dropped to quite a low level in ten days ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A,B,E and [S2A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)). Xcn5 and Xcn6 appeared after the formation of Xcn1 and Xcn2 and then continued to accumulate in significant amounts following the consumption of Xcn1 and Xcn2 in ten days ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C--E and [S2A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)), which is in line with the proposed conversion pathways in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}. However, in cultures grown with resin X-5, the yield of Xcn1 increased significantly in the first three days and then kept at a relatively high level in the following seven days ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A and [S2B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)). The yield of Xcn1 treated with X-5 was increased from 42.5 to 73.8 μg/mL (1.7-fold) and 12.9 to 60.3 μg/mL (4.7-fold) with respect to the control on the third and tenth day, respectively. Correspondingly, low levels of Xcn5 and Xcn6 were observed in the treatment ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C--E and [S2B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)), suggesting that resin X-5 somehow protected Xcn1 and Xcn2 against conversion or degradation. Next, we carried out the agar diffusion plate assay and the growth inhibition assay against *Bacillus subtilis* and *Alternaria solani*, respectively, to test whether the higher yield of Xcn1 gave a corresponding greater antibiotic activity. As expected, in comparison with the control, the zone of inhibition against *B. subtilis* increased from 20.7 to 26.8 mm ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}F and [S3A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)), while the colony growth diameter of *A. solani* decreased by 6.8 mm in resin X-5 treatment ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}G and [S3B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)), indicating higher antibiotic activity.

![Effects of adsorber X-5 on yields of Xcn1 and its derivatives. (A) Concentration dynamic curve of Xcn1 detected by high-performance liquid chromatography (HPLC) during the fermentation process. (B) Concentration dynamic curve of Xcn2. (C) Concentration dynamic curve of Xcn5. (D) Concentration dynamic curve of Xcn6. (E) HPLC analysis of Xcn1 and its derivatives in the fermentation process, and all chromatograms are normalized based on the same ratio. (F) Antibacterial activity of isolated compounds from the culture of *X. nematophila* CB6 against *B. subtilis*. The clear zone surrounding the well was measured for comparing the inhibiting effect. Control, the compounds were extracted from the culture of *X. nematophila* CB6 by adding 2% (v/v) of resin X-5 to the harvested supernatant after fermentation; resin, the compounds were extracted from the culture of *X. nematophila* CB6 by adding 2% (v/v) of resin X-5 to the CLB medium before fermentation. (G) Antifungal activity of isolated compounds from the culture of *X. nematophila* CB6 against *A. solani* measured by the growth inhibition assay. The colony growth diameter of *A. solani* on the potato dextrose agar (PDA) plate was measured for comparing the inhibiting activity. PDA, *A. solani* grown on the PDA plate; control, *A. solani* grown on the PDA plate containing the compounds extracted as described above; resin, *A. solani* grown on the PDA plate containing the compounds extracted as described above.](ao0c02357_0002){#fig2}

Effect of ISPR on Metabolic Activity and Gene Expression of *X. nematophila* CB6 {#sec2.2}
--------------------------------------------------------------------------------

Prompted by the improved yield of Xcn1 in ISPR treatment, we tested the effect of X-5 on cell density and metabolic activity, both of which could contribute to the yield of Xcn1. Our experimental data from a fermentation process revealed that X-5 affected the growth of *X. nematophila* CB6, resulting in a decreased cell density ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)). It is postulated that the adsorption of X-5 for medium components and intermediate metabolites of *X. nematophila* CB6 during fermentation interfered with the growth of *X. nematophila* CB6. Therefore, it might be cell metabolic activity rather than cell density that improved the yield of Xcn1. The former appeared to be the case since the metabolic activity of *X. nematophila* CB6, grown in the presence of resin X-5, increased remarkably compared to the control ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A). However, in both control and treated samples, the respective cell metabolic activity decreased sharply after the second day ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A). This corresponded to the consumption of reducing sugar ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B). The yield of Xcn1 reaching a plateau in three days ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A) appeared to be closely related to the cell metabolic activity of *X. nematophila* CB6 and consumption of reducing sugar. To extend the cell viability, we tried adding glucose on the second day of fermentation. However, no appreciable improvement in the yield of Xcn1 was observed, and the reason is not known at this time.

![Effect of X-5 on the cellular metabolic process and Xcn1-biosynthesis-related gene transcription of *X. nematophila* CB6. (A) Metabolic activity of *X. nematophila* CB6 in treatment and control measured by the 3-(4,5-dimethylthiazol-2-yl)--2,5-diphenyltetrazolium bromide (MTT) assay. (B) Reducing sugar concentration during fermentation was measured by the 3,5-dinitrosalicylic acid (DNS) method. (C) Relative transcription level of Xcn1-biosynthesis-related genes (*xcnA*, *xcnB*, *xcnF*, *xcnH*, *xcnK*, and *ompR*) was measured by real-time quantitative polymerase chain reaction (RT-qPCR), and all of the data were normalized based on the expression of *recA*. Data was shown as means ± standard errors (SEs).](ao0c02357_0003){#fig3}

In the biosynthetic gene cluster of Xcn1, *xcnA* and *xcnK* encoded two nonribosomal peptide synthetases (NRPS); *xcnF*, *xcnH*, and *xcnL* encoded three polyketide synthases (PKSs); and *xcnB, xcnC*, and *xcnE* were predicted to be involved in hydroxymalonyl CoA synthesis. We further investigated the effect of resin X-5 on the transcription of some crucial genes in the biosynthetic gene clusters of Xcn1 ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)),^[@ref19],[@ref32]^ namely, *xcnA*, *xcnB*, *xcnF*, *xcnH*, and *xcnK*. Relative to the control, transcription of these genes in resin X-5 treatment was upregulated by 3.7--10.3 fold ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C), consistent with the higher yield of Xcn1. However, transcription of these genes declined evidently after 6 h in the culture process, especially *xcnA*, the NRPS encoding gene of Xcn1 biosynthetic pathway, implying that the biosynthesis of Xcn1 was repressed at the transcriptional level. As a global regulator, OmpR repressed the transcription of *xcnA-L* but enhanced the transcription of *xcnMN* in *X. nematophila.*([@ref32],[@ref44]) However, the transcription of the *ompR* gene showed a similar trend to *xcnA-L* in the present research, speculating that resin addition might lead to intracellular transcriptional reprogramming. In summary, these results demonstrated that the removal of Xcns by resin remarkably increased cell metabolic activity and also upregulated the transcription of biosynthesis-related genes of Xcn1.

Metabolite Analysis of *X. nematophila* CB6 Treated by Resin X-5 {#sec2.3}
----------------------------------------------------------------

Two unknown products, with retention times being 7.93 and 10.96 min, respectively, were detected by high-performance liquid chromatography (HPLC) due to their remarkably enhanced yield in the resin X-5-treated sample ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)). It was presumed that the positive regulation of operons of specific gene clusters or the limiting effect against metabolite degradation caused by resin X-5 contribute to the accumulation of the two unknown products. Therefore, resin X-5-mediated ISPR might interfere with the metabolic process of *X. nematophila* CB6 and facilitate the discovery of potentially new metabolites. To confirm the phenomenon observed experimentally, an untargeted metabolomic analysis of the extracts was performed by ultrahigh-performance liquid chromatography--mass spectrometry (UPLC--MS). A total of 2943 metabolites were identified in all samples, including 852 differential metabolites based on the criteria of variable influence on projection (VIP) \> 1.0 and *P*-value \< 0.05 ([Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf) and [Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf)) and 626 differential metabolites appeared to be new ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A). We analyzed 226 of the known differential metabolites and found that 103 were upregulated and 123 were downregulated ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B). According to chemical classification, the annotated metabolites could be categorized into nine groups: alkaloids and derivatives, benzenoids, lipids and lipidlike molecules, organic nitrogen compounds, organic acids and derivatives, organic oxygen compounds, organoheterocyclic compounds, organo-oxygen compounds, and phenylpropanoids and polyketides ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C). Interestingly, some dipeptides and nonribosomal peptides, such as arginyl--alanine, mauritine A, sakacin A, enalapril, neuromedin N, and triiodothyronine sulfate, the potential precursor of the antibacterial material, were upregulated by 1.4--32.4 fold due to resin treatment. Sakacin A, which is a class IIa, pediocin-like antilisterial bacteriocin, can inhibit the growth of several lactic acid bacteria and *Listeria monocytogenes.*([@ref45],[@ref46]) Furthermore, based on the hierarchical clustering analysis, some compounds that possess potential pharmacological activity were significantly upregulated because of resin X-5 treatment ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}D). These include 7-epizucchini factor A, goyaglycoside-a,^[@ref47]^*N*-desmethylmirtazapine,^[@ref48]^ 2,3-dinor-TXB1,^[@ref49]^ and 1-methoxy-1-(2,4,5-trimethoxyphenyl)-2-propanol. The identified differential metabolites were annotated in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database and enriched in 14 prominent pathways ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}E) that are involved in the biosynthesis and metabolism of amino acids, glycerophospholipids, carbapenem biosynthesis, and quorum sensing. In summary, ISPR treatment remarkably altered the metabolite profile of *X. nematophila* CB6 that resulted in the enrichment of some intermediate metabolites.

![Untargeted metabolomic analysis of the metabolite profile of *X. nematophila* CB6 treated by resin X-5. (A) Classification of total differential metabolites. (B) Classification of 226 identified differential metabolites. (C) Distribution of differential metabolites based on chemical classification. (D) Hierarchically clustered heatmap of differential metabolites. (E) Scatter plot of differential metabolites enriched in the KEGG pathway.](ao0c02357_0004){#fig4}

Conclusions {#sec3}
===========

In conclusion, with the help of ISPR, the yield of Xcn1 was improved significantly during the fermentation process, accompanied by an improved antibiotic activity against *B. subtilis* and *A. solani*. The improved yield of Xcn1 apparently resulted from three factors: improvement of the cell metabolic activity of *X. nematophila* CB6 by minimizing Xcn1 accumulation, the protective role of resin X-5 for Xcn1 against conversion or degradation, and upregulation of biosynthesis-related genes of Xcn1 at the transcriptional level. In addition, resin X-5 significantly altered the metabolite profile of *X. nematophila* CB6, especially some dipeptides and nonribosomal peptides. Therefore, the increased antimicrobial activity might be the synergistic effects of these compounds acting together with Xcn1 and its derivatives as well as some still unknown compounds. Finally, we anticipate that the application of ISPR coupled with metabolite engineering could further improve the yield of Xcn1, accelerating the development process of Xcn1 as a new biofungicide in plant protection.

Materials and Methods {#sec4}
=====================

Strain, Media, and Growth Conditions {#sec4.1}
------------------------------------

*X. nematophila* var. *pekingensis* CB6 was isolated from entomopathogenic nematode *Steinernema* sp. screened from a soil sample in Beijing, China. *B. subtilis* utilized in this study was a strain stored in our lab. *A. solani* was kindly provided by Professor Qinying Wang (Agriculture University of HeBei, China). *X. nematophila* CB6 was inoculated in 5 mL of CLB medium (1.0% tryptone, 0.5% yeast extract, 0.5% NaCl, 0.01 mM MgSO~4~) and cultured at 30 °C with shaking at 200 rpm for 12 h. The preculture was scaled up to 100 mL of CLB medium at an initial OD~600~ of 0.1 and then incubated for the desired period depending on the type of experiments as follows. *B. subtilis* were grown at 37 °C in liquid LB medium, and *A. solani* were grown at 25 °C on potato dextrose agar (PDA).

Extraction of Xenocoumacin and Its Derivatives {#sec4.2}
----------------------------------------------

The nonpolar macroporous resin X-5 could efficiently extract Xcn1 and its derivatives from fermentation broth.^[@ref50]^ We employed two conditions for extracting the desired chemicals from the culture of *X. nematophila* CB6: first, 2% (v/v) of resin X-5 was added to 100 mL of CLB medium before fermentation, that is, before inoculating *X. nematophila* CB6; second, resin X-5 was added to the harvested supernatant after fermentation as a control. Resin X-5 was separated from cells and the supernatant by filtration and then extracted twice with MeOH (1 × 100 mL, 1 × 50 mL), and the combined extract was concentrated to dryness using a rotary evaporator. The residue was redissolved in ddH~2~O and then filtered through a 0.22 μm pore size syringe microfilter for HPLC analysis. The condition for HPLC analysis is as follows: an Agilent C18 column (4.6 mm × 150 mm), with ddH~2~O containing 0.1% formic acid/acetonitrile (70:30) serving as the mobile phase.

Cell Density Assay {#sec4.3}
------------------

For measuring the cell density, the optical density at 600 nm \[OD~600~\] of *X. nematophila* CB6 was monitored at predetermined time points. The experiments were done in triplicate.

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) Assay {#sec4.4}
------------------------------------------------------------------------

The metabolic activity of *X. nematophila* CB6 was measured by the MTT assay as reported previously.^[@ref51]^ The harvested cells were washed three times with sterilized phosphate-buffered saline (PBS) buffer and then resuspended in the same buffer, following the kit instructions (Beyotime, C0009).

Quantification of Reducing Sugars {#sec4.5}
---------------------------------

The reducing sugar content was determined using the 3,5-dinitrosalicylic acid (DNS) method.^[@ref52]^ The supernatant (1 mL) of culture, collected during fermentation, was mixed with 1 mL of DNS reagent and then heated at 100 °C for 15 min. The absorbance was monitored at 540 nm by an ultraviolet--visible (UV--vis) spectrometer. The content of reducing sugars was determined by comparing it to a standard curve created by glucose at different concentrations.

Real-Time Quantitative PCR (RT-qPCR) {#sec4.6}
------------------------------------

The bacterial total ribonucleic acid (RNA) was extracted using the Bacterial RNA Extraction Kit (Vazyme, R403-01). All of the quantitative PCR reactions were performed using SYBR Green qPCR SuperMix (TransGen Biotech, AQ132-14) according to the instructions. PCR conditions are as follows: 95 °C for 30 s, (95 °C for 5 s, 60 °C for 34 s) × 40 cycles. To compare the difference of transcription between the control and resin X-5 treatment, the relative transcription abundance (ΔΔ*C*~T~) was measured by the formula ΔΔ*C*~T~ = Δ*C*~T~ (X-5 treatment) -- Δ*C*~T~ (control), where the relative transcription abundance of the tested gene (Δ*C*~T~) was calculated by Δ*C*~T~ = *C*~T~(tested gene) -- *C*~T~(reference gene). Relative gene transcription was determined by the 2^--ΔΔ*C*~T~^ method, and one-way analysis of variance (ANOVA) was performed for analyzing the difference at the statistical level. The RT-qPCR primers for measuring Xcn1 biosynthetic related genes are listed in [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf).

Antibiotic Activity Assay {#sec4.7}
-------------------------

The antibacterial activity of the compounds, extracted from the culture of *X. nematophila* CB6, against *B. subtilis* was measured by the agar diffusion plate assay.^[@ref53]^ Sample wells were prepared on a two-layer agar diffusion plate, in which 20 mL of medium containing 0.75% agar and 10^7^--10^8^ colonies of *B. subtilis* were layered above 10 mL of 2% sterilized agar. The extract (100 μL) prepared as described above was added to the well, and after 24 h incubation at 37 °C, the clear inhibition zone surrounding the well was measured and compared.

To test the antifungal activity of isolated compounds from *X. nematophila* CB6, an *A. solani* strain that is sensitive to Xcn1 was chosen as a model fungus based on its growth inhibition. Briefly, the tested sample was mixed with the PDA medium with a final concentration of 5 or 10% and then poured onto a Petri dish. The mycelia PDA block was cut from the edges of a three-day colony of *A. solani* growing on PDA and then placed at the center of the plate for culturing at 28 °C. After three days, the diameter of growth inhibition was measured.

Metabolomic Analysis by LC--MS {#sec4.8}
------------------------------

The metabolomic profiling of the isolated compounds of resin X-5 from *X. nematophila* CB6 under different conditions was analyzed by LC--MS. Specifically, 20 μL of 2-chloro-[l]{.smallcaps}-phenylalanine (0.3 mg/mL) dissolved in methanol as an internal standard was added to 1 mL of sample, then lyophilized, and redissolved in 300 μL of methanol/acetonitrile (2:1, v/v). The sample was vortexed for 30 s and placed at 4 °C for 2 min, after which it was centrifuged at 13 000 rpm and 4 °C for 15 min. The supernatant was transferred into a new glass vial and then lyophilized again. The residue was redissolved in 300 μL of methanol and water (1:4, v/v) and filtered through 0.22 μm microfilters for LC--MS analysis. LC--MS was performed on an ACQUITY UPLC system (Waters Corporation, Milford) coupled with an AB SCIEX Triple TOF 5600 System (AB SCIEX, Framingham, MA). The conditions for HPLC separation are as follows: An ACQUITY BEH C18 column (100 mm × 2.1 mm i.d., 1.7 μm; Waters Corporation) is employed in both positive and negative modes; the injection volume is 10 μL; mobile phase A is water containing 0.1% formic acid; mobile phase B is acetonitrile/methanol (2:3, v/v) containing 0.1% formic acid; and the linear gradient is 0 min, 1% B; 1 min, 30% B; 2.5 min, 60% B; 6.5 min, 90% B; 8.5 min, 100% B; 10.7 min, 100% B; 10.8 min, 1% B; and 13 min, 1% B. During separation, the flow rate was 0.4 mL/min and the column temperature was 45 °C. Quality control (QC) samples, which were prepared by pooling aliquots of all of the samples into one, were injected at regular intervals (every ten samples) throughout the analytical run to provide a set of data from which repeatability can be measured.

Metabolite Identification and Statistical Analysis {#sec4.9}
--------------------------------------------------

The acquired LC--MS raw data were converted by Progenesis QI software (Waters Corporation, Milford), as previously described.^[@ref54]^ In this study, we set the parameters as follows: precursor tolerance, 5 ppm; fragment tolerance, 10 ppm; and retention time (RT) tolerance, 0.02 min. Internal standard detection parameters were deselected for peak RT alignment, isotopic peaks were excluded from analysis, the noise elimination level was set at 10.00, and the minimum intensity was set to 15% of the base peak intensity. Finally, the data matrix (.xls) was obtained with three-dimensional data sets including *m*/*z*, peak RT, and peak intensity. Each ion was identified by RT--*m*/*z* pairs, and the peaks with missing values (ion intensity = 0) in more than 50% of samples were removed from the data matrix. The internal standard was used for QC data. Also, the metabolites were identified by QI Data Processing Software through public databases (<http://www.hmdb.ca/>, <http://www.lipidmaps.org/>) and self-built databases.

Principle component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) were performed for visualizing the differential metabolites between the control and treatment, after mean centering (Ctr) and Pareto variance (Par) scaling, respectively.^[@ref55]^ The default seven-round cross validation was performed to guard against overfitting. The differential metabolites were determined on the basis of the combination of a statistically significant threshold of variable influence on projection (VIP) values obtained from the OPLS-DA model and Student's *t*-test (*P* values) on the normalized peak areas, where metabolites with VIP values larger than 1.0 and *P*-values less than 0.05 were considered as differential metabolites. The pathway annotation analysis was conducted by the compound identification number (CID) in the Kyoto Encyclopedia of Genes and Genomes (KEGG, <https://www.genome.jp/kegg/pathway.html>) database. Metabolite classification, prominent metabolic pathway detection, and enrichment analyses were also carried out.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c02357](https://pubs.acs.org/doi/10.1021/acsomega.0c02357?goto=supporting-info).Characterization of Xenocoumacin 1 biosynthesis gene cluster in *X. nematophila* CB6 (Figure S1); ratios of Xcn1 and its derivatives in different cultivation processes (Figure S2); role of resin addition in antibiotic activity (Figure S3); effect of resin addition on growth of *X. nematophila* CB6 (Figure S4); effect of resin X-5 on the yield of two unknown products (Figure S5); quality control of untargeted metabolomic data (Figure S6); list of RT-qPCR primers used in this study (Table S1) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_001.pdf))Detailed information about all of the metabolites detected in the control and resin group samples (Table S2) ([XLSX](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02357/suppl_file/ao0c02357_si_002.xlsx))
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